Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 499.41M P/E - EPS this Y -15.60% Ern Qtrly Grth -
Income -60.84M Forward P/E -8.32 EPS next Y 16.80% 50D Avg Chg 3.00%
Sales 68.67M PEG -0.20 EPS past 5Y - 200D Avg Chg 25.00%
Dividend N/A Price/Book 3.74 EPS next 5Y 20.10% 52W High Chg -46.00%
Recommedations 1.80 Quick Ratio 5.62 Shares Outstanding 38.81M 52W Low Chg 225.00%
Insider Own 4.67% ROA -20.84% Shares Float 36.98M Beta 0.60
Inst Own 92.85% ROE -44.69% Shares Shorted/Prior 1.73M/1.04M Price 13.23
Gross Margin 73.90% Profit Margin -88.60% Avg. Volume 239,400 Target Price 16.20
Oper. Margin -72.20% Earnings Date May 1 Volume 203,025 Change -4.20%
About Pulmonx Corporation

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Pulmonx Corporation News
04/10/24 Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
04/02/24 Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
03/15/24 Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02/29/24 Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp
02/26/24 Pulmonx Announces Treatment of the First Patient with the AeriSealĀ® System in CONVERT II Pivotal Trial
02/24/24 US$16.50 - That's What Analysts Think Pulmonx Corporation (NASDAQ:LUNG) Is Worth After These Results
02/23/24 Pulmonx Full Year 2023 Earnings: Beats Expectations
02/22/24 Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript
02/22/24 Q4 2023 Pulmonx Corp Earnings Call
02/21/24 Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses
02/21/24 Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
02/21/24 Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
02/17/24 Insider Sell: President and CEO French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG)
02/07/24 Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
12/22/23 Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG)
12/11/23 The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors
11/17/23 Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
11/15/23 Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
10/31/23 Pulmonx to Participate at Upcoming Investor Conferences
10/31/23 Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript
LUNG Chatroom

User Image insiderbuyingselling Posted - 3 days ago

$LUNG new insider selling: 1184 shares. http://insiderbuyingselling.com/?t=LUNG

User Image FiveKegs Posted - 1 week ago

$LUNG this will drop sub $5. Earnings not growing fast enough to support expenses Once it falls below $5 will accelerate to sub $2 May not like it but trust me on this one

User Image Stock_Titan Posted - 2 weeks ago

$LUNG Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024 https://www.stocktitan.net/news/LUNG/pulmonx-to-report-first-quarter-2024-financial-results-on-may-1-t2spr780ylvm.html

User Image lefthanging Posted - 3 weeks ago

$LUNG 4 quarterly beats in a row....can't help but believe this was taken down for loading....brutal though....

User Image MGAP Posted - 3 weeks ago

$LUNG heading towards a 52 week low

User Image RocketThief Posted - 3 weeks ago

$LUNG volume again quite low, upped position

User Image RocketThief Posted - 3 weeks ago

$LUNG low volume dip, good time to add

User Image insiderbuyingselling Posted - 1 month ago

$LUNG new insider selling: 1184 shares. http://insiderbuyingselling.com/?t=LUNG

User Image jimmyhunt Posted - 1 month ago

$LUNG nice

User Image Maajk Posted - 1 month ago

$LUNG Hoping for a jump back to 14$. 8.86 average here

User Image Stock_Titan Posted - 1 month ago

$LUNG Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/LUNG/pulmonx-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-l3bscd7uam5n.html

User Image jimmyhunt Posted - 1 month ago

$LUNG 8.99 ave now

User Image RocketThief Posted - 1 month ago

$LUNG bought some today

User Image johnmilnes Posted - 1 month ago

$LUNG Bounce potential from these levels.

User Image insiderbuyingselling Posted - 1 month ago

$LUNG new insider selling: 6954 shares. http://insiderbuyingselling.com/?t=LUNG

User Image jimmyhunt Posted - 02/29/24

$LUNG 9.38 for me

User Image FarmHunter Posted - 02/28/24

$LUNG Getting hit hard with management changes, which seems excessive. CEO moving to the board, so he will still be around. WAY oversold here.

User Image FarmHunter Posted - 02/28/24

$LUNG https://www.medicaldevice-network.com/news/pulmonx-first-aeriseal-copd/

User Image FarmHunter Posted - 02/28/24

$LUNG https://finance.yahoo.com/news/us-16-50-thats-analysts-130453355.html

User Image RocketThief Posted - 2 months ago

$LUNG will be interested after they raise cash

User Image tradingtwenty Posted - 2 months ago

Top 5 oversold stocks that have trended in the past 24 hours: $ASTI 22.98 šŸ”„ $LUNG 24.21 $ATLX 24.51 $IRDM 24.63 $IRBT 25.24 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past

User Image tradingtwenty Posted - 2 months ago

Top 5 oversold stocks that have trended in the past 24 hours: $SELX 18.77 šŸ”„ $IRBT 20.70 $RIVN 22.80 $CAR 22.99 $LUNG 26.02 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past

User Image Ninja_Tradez Posted - 2 months ago

šŸ“¢ $LUNG - Pulmonx Announces Treatment of the First Patient with the AeriSealĀ® System in CONVERT II Pivotal Trial https://newsfilter.io/a/c38e5498d291b9255e862bed2f63c760

User Image TheTradeXchange Posted - 2 months ago

$LUNG - Pulmonx Announces Treatment of the First Patient with the AeriSealĀ® System in CONVERT II Pivotal Trial

User Image Stock_Titan Posted - 2 months ago

$LUNG Pulmonx Announces Treatment of the First Patient with the AeriSealĀ® System in CONVERT II Pivotal Trial https://www.stocktitan.net/news/LUNG/pulmonx-announces-treatment-of-the-first-patient-with-the-aeri-seal-c1u2ouq4ysxa.html

User Image _www_larval_com_ Posted - 2 months ago

$CPOP 7%[22%] $LUNG -7%[-13%] $GSHD 6%[-16%] $TRVI -5%[4%] $APLT -5%[9%] most notable movement within the first minutes of trading.

User Image Stock_Titan Posted - 2 months ago

$LUNG Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/LUNG/pulmonx-reports-fourth-quarter-and-full-year-2023-financial-qnigo5ctqm7x.html

User Image insiderbuyingselling Posted - 2 months ago

$LUNG new insider selling: 20000 shares. http://insiderbuyingselling.com/?t=LUNG

User Image Stock_Titan Posted - 2 months ago

$LUNG Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024 https://www.stocktitan.net/news/LUNG/pulmonx-to-report-fourth-quarter-and-full-year-2023-financial-et6x6vjdenh2.html

User Image Doozio Posted - 2 months ago

If itā€™s šŸ§ ā° for MSOS itā€™s šŸ§ ā° for YO $lung TTWO

Analyst Ratings
Piper Sandler Overweight Apr 3, 24
Citigroup Buy Feb 23, 24
Wells Fargo Equal-Weight Feb 23, 24
Stifel Buy Feb 22, 24
Piper Sandler Overweight Feb 22, 24
Wells Fargo Overweight Feb 22, 24
Piper Sandler Overweight Oct 31, 23
Canaccord Genuity Buy Oct 31, 23
Craig-Hallum Buy Sep 5, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Rose Geoffrey Beran CHIEF COMMERCIAL OFF.. CHIEF COMMERCIAL OFFICER Jan 22 Sell 13.13 1,184 15,546 244,233 01/24/24
French Glendon E. III PRESIDENT AND CEO PRESIDENT AND CEO Jan 18 Sell 12.77 10,000 127,700 1,141,344 01/22/24
French Glendon E. III President and CEO President and CEO Dec 21 Sell 12.42 10,000 124,200 1,151,344 12/22/23
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Nov 22 Sell 10.60 1,184 12,550 249,469 11/27/23
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Oct 23 Sell 8.35 1,184 9,886 250,653 10/25/23
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Sep 22 Sell 10.51 1,184 12,444 251,837 09/26/23
Sung Derrick Chief Financial Offi.. Chief Financial Officer Sep 01 Sell 10.01 4,219 42,232 391,041 09/06/23
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Sep 01 Sell 10.01 2,843 28,458 253,021 09/06/23
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Aug 23 Sell 10.54 1,184 12,479 255,864 08/25/23
French Glendon E. III President and CEO President and CEO Jul 20 Sell 12.68 15,000 190,200 1,174,547 07/24/23
Sung Derrick Chief Financial Offi.. Chief Financial Officer Jun 01 Sell 11.49 4,222 48,511 395,260 06/02/23
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Jun 01 Sell 11.48 2,845 32,661 257,048 06/02/23
Lehman David Aaron General Counsel General Counsel Jun 01 Sell 11.48 3,776 43,348 157,420 06/02/23
French Glendon E. III President and CEO President and CEO Jun 01 Sell 11.48 6,533 74,999 1,199,547 06/02/23
French Glendon E. III President and CEO President and CEO Mar 01 Sell 11.03 2,895 31,932 1,032,580 03/03/23
French Glendon E. III President and CEO President and CEO Dec 01 Sell 5.93 3,631 21,532 1,034,313 12/05/22
Lehman David Aaron General Counsel General Counsel Dec 01 Sell 5.93 1,069 6,339 44,160 12/05/22
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Dec 01 Sell 5.93 1,055 6,256 181,037 12/05/22
Sung Derrick Chief Financial Offi.. Chief Financial Officer Dec 01 Sell 5.93 1,069 6,339 262,746 12/05/22
Lynch Alissa Hsu Director Director Nov 29 Buy 5.51 1,700 9,367 11,910 12/01/22
Ferrari Richard Director Director Nov 08 Buy 5.3 5,438 28,821 30,035 11/10/22
Sung Derrick Chief Financial Offi.. Chief Financial Officer Sep 01 Sell 17.87 1,082 19,335 253,815 09/06/22
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Sep 01 Sell 17.89 1,027 18,373 182,092 09/06/22
Lehman David Aaron General Counsel General Counsel Sep 01 Sell 17.89 1,082 19,357 45,229 09/06/22
French Glendon E. III President and CEO President and CEO Sep 01 Sell 17.87 2,940 52,538 1,052,944 09/06/22
French Glendon E. III President and CEO President and CEO Aug 18 Sell 20.59 50,000 1,029,500 1,055,884 08/22/22
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Jun 01 Sell 18.05 1,011 18,249 183,118 06/03/22
Sung Derrick Chief Financial Offi.. Chief Financial Officer Jun 01 Sell 18.05 1,065 19,223 254,897 06/03/22
French Glendon E. III President and CEO President and CEO Jun 01 Sell 18.05 2,523 45,540 1,104,994 06/03/22
Lehman David Aaron General Counsel General Counsel Jun 01 Sell 18.05 1,065 19,223 46,311 06/03/22
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Mar 10 Option 2.10 29,427 61,797 184,129 03/11/22
Sung Derrick Chief Financial Offi.. Chief Financial Officer Mar 01 Sell 25.91 458 11,867 224,962 03/03/22
Rose Geoffrey Beran Chief Commercial Off.. Chief Commercial Officer Mar 01 Sell 25.91 426 11,038 123,702 03/03/22
Lehman David Aaron General Counsel General Counsel Mar 01 Sell 25.91 458 11,867 16,376 03/03/22
French Glendon E. III President and CEO President and CEO Mar 01 Sell 25.91 1,132 29,330 1,062,817 03/03/22
French Glendon E. III President and CEO President and CEO Feb 17 Sell 27.05 25,000 676,250 1,063,949 02/22/22
French Glendon E. III President and CEO President and CEO Jan 20 Sell 24.91 25,000 622,750 1,088,949 01/24/22
French Glendon E. III President and CEO President and CEO Dec 16 Sell 31.33 25,000 783,250 1,113,949 12/17/21
Sung Derrick Chief Financial Offi.. Chief Financial Officer Dec 14 Sell 31.66 6,000 189,960 225,420 12/16/21
French Glendon E. III President and CEO President and CEO May 20 Option 2.2 10,000 22,000 1,259,884 12/03/21
French Glendon E. III President and CEO President and CEO May 20 Sell 41.6 25,000 1,040,000 1,234,884 12/03/21
French Glendon E. III President and CEO President and CEO Apr 15 Option 2.2 25,000 55,000 1,274,884 12/03/21
French Glendon E. III President and CEO President and CEO Apr 15 Sell 43.93 25,000 1,098,250 1,249,884 12/03/21
French Glendon E. III President and CEO President and CEO Nov 18 Sell 36.51 25,000 912,750 1,105,370 11/22/21
French Glendon E. III President and CEO President and CEO Oct 21 Sell 39.81 25,000 995,250 1,130,370 10/22/21